Product Information

TIMOLOL 0.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $20.6146 per ML under NDC 82260004505. Its NADAC has been published 106 times since Nov 6, 2024.

FDA first approved this application on Jun 4, 2004. Its Orange Book therapeutic-equivalence code is AT2.

The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIMOLOL 0.5% EYE DROP

Timolol Maleate
$20.6146per ML
High Outlier

Strength

5 mg/mL

NDC

82260004505

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

TIMOLOL MALEATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021516

FDA Approved

6/4/2004

TE Code

AT2

On Market Since

6/23/2022

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TIMOLOL 0.5% EYE DROP has been published 106 times since Nov 6, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.

Current price$20.6146 per ML
All-time high$24.7668 (Jan 15, 2025)
All-time low$15.4754 (Nov 19, 2025)
52-week high$23.6912
52-week low$15.4754
Median price$20.5078
Average price$20.2425
Largest weekly change-14.2% (Jan 22, 2025)
Weeks tracked106
Tracking sinceNov 6, 2024

Price History

1W

0.0%

1M

-7.5%

3M

-13.0%

6M

-7.2%

1Y

+26.6%

3Y

N/A

5Y

N/A

All

-16.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 14%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIMOLOL 0.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $20.6146 per ML (NDC 82260004505), effective Nov 11, 2026.

How has the price of TIMOLOL 0.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for TIMOLOL 0.5% EYE DROP has declined 16.8%. It has been tracked across 106 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% EYE DROP?

Since Nov 6, 2024, the NADAC for TIMOLOL 0.5% EYE DROP has ranged from a low of $15.4754 (Nov 19, 2025) to a high of $24.7668 (Jan 15, 2025), with a median of $20.5078 per ML.

Are there cheaper alternatives to TIMOLOL 0.5% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL 0.5% EYE DROP, is $17.7216 per ML — about 14% below TIMOLOL 0.5% EYE DROP.

Who manufactures TIMOLOL 0.5% EYE DROP?

TIMOLOL 0.5% EYE DROP (NDC 82260004505) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.